Probable 12 million plus net income-order 5 of 20k tons

New Post Public Reply Private Reply Replies (0) Message Board
microcaps

Probable 12 million plus net income-order 5 of 20k tons reported sold months ago on ihub by somebody else-based on thousands of hours dd rather than baseless satirical comments

Kriton left with 38524/tons Apr 2nd 2011-price was unknown but was reportedly more than the 155 somebody posted at the time-spot was 175-192 during that time-both 58% and 62% ore (hadn't reportedly acquired previous 68 drill hole reports yet which led to Coloso vein from whence Loreto ore and all subsequent ore came except for substantial 1-3mm already in inventory) millions of cash contributions from investors were paid off from just 30% of the income from this ship alone

Loreto left Aug 8 w 36002 tons- ca 170/ton spot- 1st order to come from the higher quality veins see Aug 8 PR (not on marketwire)

the 3rd ship has now left with 43829 tons,just as forecast by the Nov 17 PR,which said the next ship would be 40-45k tons. Somebody else discovered the ship-its called dd -and then we tracked the ship via various public ship tracking sites-its again called dd.

4th ship expected in August-probably for the ca 75k tons sinter fines processed by the trommel -see last 2 PR's

shipments 3 and 4 (ca 60 k tons total) paid for in Dec -thus all the millions in new equipment--1 independent source says for 140/ton-about right- spot was ca 140 then (now ca 148 last I knew) plus premium ore

so 134526 tons sold in 2011 for ca 155/ton average or more
-some juniors have negative cost due to premium ore (5/ton for every % over 62%) see Cohibaman's article in Max's dd summary so avg jr miner cost is ca 25/ton plus shipping and trucking (trucking was 9.24/ton for Loreto) 1st 2 loads shipping were ca 30/ton but a Panamax shouldnt be more than 15/ton?as per my extensive calculations posted on other board back in October

so cost of ca 65/ton or less and profit of 90/ton but to be safe I only estimated 75/ton profit times 134526 tons is $10,089,000 net income plus 5th order of ca 1.25 million profit (trying to be conservative) so total profit to date plus revenue from other products like the cement totals a probable profit of ca 12 million.

start up costs probably raise costs and are unknown but
going forward costs will fall and ancillary income streams of sub 1mm iron chips, fertilizer will kick in- CWRN already has cement revenue stream.


part of orders 3,4 and 5 was just shipped on the Qin Hai-DWT of ca 45600 tons minus ballast ,water and people resulted in 43829 tons shipped-(Nov 17 PR forecast ca 40-45k tons) now on a possible round circuit from China to save on shipping-and order 5 started trucking mid March or earlier-

-independent pics as well as CWRN pics showed order 5 trucking at port ca Mar 19-depending on size of order 5 that would be more than the max size of a Panamax-(orders 3 and 4 reportedly total 60k tons) which are rated at 60-80k/ton but cant carry more than ca 75k because have to leave room for people,fuel and ballast

fertilizer as is without any further processing brings a min of 90/ton as verified by independent sites but posted by Rocket email re possible JV plant onsite w OMRI to process fertilizer would result in 325-550/ton (550 for pelleted)see Apr 13 PR

the cheap 1.73% azomite fertilizer offered elsewhere is going for 325-550 I think and CWRN'S fert is 55.55% iron (posted SGS analysis)-will have to be diluted or cut (as the druggies say) many times-so thats good-

150k tons 1-3mm in inventory ? plus as posted ca 200k tons 0-1mm in inventory,which is now being processed or has been processed for separation into sub 1mm iron chips to be pelleted and fertilizer. as noted by at least the last 2 PR's

Cotton & Western Mining Inc. (CWRN) Stock Research Links

CWRN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading